Literature DB >> 2373264

Alterations in transfer and lipid distribution of arachidonic acid in placentas of diabetic pregnancies.

D C Kuhn1, M A Crawford, M J Stuart, J J Botti, L M Demers.   

Abstract

Placental tissue from nondiabetic term pregnancies and pregnancies complicated by maternal insulin-dependent diabetes mellitus (IDDM) was perfused in vitro to compare the transfer and lipid distribution of arachidonic acid (AA). Radiolabeled albumin-bound AA was administered into the maternal afferent circulation, and samples of fetal and maternal effluent were collected at 10-min intervals. Perfused placental tissue was collected at the end of each experiment. The effluent was analyzed for total radioactivity, and extracts were subjected to thin-layer chromatography for the assessment of radioactivity associated with various lipid fractions. Placental AA uptake was significantly increased in perfused tissue from diabetic pregnancies (0.88 vs. 1.72 nM.min-1.g-1 in nondiabetic and IDDM, respectively; P less than 0.01), as was AA transfer (0.22 vs. 0.42 ml/min in nondiabetic and IDDM, respectively; P less than 0.01). However, transfer of the highly diffusible marker substance antipyrine was significantly reduced in IDDM placentas (1.79 vs. 2.49 ml/min in IDDM and nondiabetic, respectively; P less than 0.01). Compared with nondiabetic placentas, incorporation of AA into triglyceride was significantly increased in both maternal and fetal effluents and in placental tissue from IDDM pregnancies, whereas the percentage of AA remaining unesterified was reduced in both placental tissue and fetal effluent. Incorporation of AA into phosphoglycerides was significantly reduced in placental tissue but increased in fetal effluent in placentas from IDDM pregnancies. The results of these studies suggest that transfer and lipid distribution of AA are significantly altered in placentas from IDDM pregnancies. These findings may be relevant to the increased incidence of abnormal fetal growth and development associated with IDDM pregnancies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373264     DOI: 10.2337/diab.39.8.914

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  5 in total

1.  Gestational diabetes mellitus enhances arachidonic and docosahexaenoic acids in placental phospholipids.

Authors:  Demetris Bitsanis; Kebreab Ghebremeskel; Therishnee Moodley; Michael A Crawford; Ovrang Djahanbakhch
Journal:  Lipids       Date:  2006-04       Impact factor: 1.880

2.  Fetal erythrocyte phospholipid polyunsaturated fatty acids are altered in pregnancy complicated with gestational diabetes mellitus.

Authors:  V Wijendran; R B Bendel; S C Couch; E H Philipson; S Cheruku; C J Lammi-Keefe
Journal:  Lipids       Date:  2000-08       Impact factor: 1.880

3.  The influence of placental metabolism on fatty acid transfer to the fetus.

Authors:  Simone Perazzolo; Birgit Hirschmugl; Christian Wadsack; Gernot Desoye; Rohan M Lewis; Bram G Sengers
Journal:  J Lipid Res       Date:  2016-12-02       Impact factor: 5.922

4.  Myo-Inositol Moderates Glucose-Induced Effects on Human Placental 13C-Arachidonic Acid Metabolism.

Authors:  Oliver C Watkins; Victoria K B Cracknell-Hazra; Reshma Appukuttan Pillai; Preben Selvam; Hannah E J Yong; Neha Sharma; Sathya Narayanan Patmanathan; Amaury Cazenave-Gassiot; Anne K Bendt; Keith M Godfrey; Rohan M Lewis; Markus R Wenk; Shiao-Yng Chan
Journal:  Nutrients       Date:  2022-09-26       Impact factor: 6.706

5.  Unique Biomarker Characteristics in Gestational Diabetes Mellitus Identified by LC-MS-Based Metabolic Profiling.

Authors:  Xingjun Meng; Bo Zhu; Yan Liu; Lei Fang; Binbin Yin; Yanni Sun; Mengni Ma; Yuli Huang; Yuning Zhu; Yunlong Zhang
Journal:  J Diabetes Res       Date:  2021-06-09       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.